|
1
|
Askoxylakis V, Thieke C, Pleger ST, Most
P, Tanner J, Lindel K, Katus HA, Debus J and Bischof M: Long-term
survival of cancer patients compared to heart failure and stroke: A
systematic review. BMC Cancer. 10:1052010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schwartz AG, Wenzlaff AS, Prysak GM,
Murphy V, Cote ML, Brooks SC, Skafar DF and Lonardo F: Reproductive
factors, hormone use, estrogen receptor expression and risk of non
small-cell lung cancer in women. J Clin Oncol. 25:5785–5792. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gondos A, Bray F, Brewster DH, Coebergh
JW, Hakulinen T, Janssen-Heijnen ML, Kurtinaitis J and Brenner H;
EUNICE Survival Working Group, : Recent trends in cancer survival
across Europe between 2000 and 2004: A model-based period analysis
from 12 cancer registries. Eur J Cancer. 44:1463–1475. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Remon J, Ahn MJ, Girard N, Johnson M, Kim
DW, Lopes G, Pillai RN, Solomon B, Villacampa G and Zhou Q:
Advanced-stage non-small cell lung cancer: Advances in thoracic
oncology 2018. J Thorac Oncol. 14:1134–1155. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Antonia SJ, Villegas A, Daniel D, Vicente
D, Murakami S, Hui R, Yokoi T, Chiappori A, Lee KH, de Wit M, et al
PACIFIC investigators, : Durvalumab after chemoradiotherapy in
stage III non-small-cell lung cancer. N Engl J Med. 377:1919–1929.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shinde A, Li R, Kim J, Salgia R, Hurria A
and Amini A: Stereotactic body radiation therapy (SBRT) for
early-stage lung cancer in the elderly. Semin Oncol. 45:210–219.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Draghiciu O, Walczak M, Hoogeboom BN,
Franken KL, Melief KJ, Nijman HW and Daemen T: Therapeutic
immunization and local low-dose tumor irradiation, a reinforcing
combination. Int J Cancer. 134:859–872. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn
J and Song JY: An effective strategy for increasing the
radiosensitivity of human lung cancer cells by blocking
Nrf2-dependent antioxidant responses. Free Radic Biol Med.
53:807–816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Provencio M, Sánchez A, Garrido P and
Valcárcel F: New molecular targeted therapies integrated with
radiation therapy in lung cancer. Clin Lung Cancer. 11:91–97. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rube CE, Uthe D, Schmid KW, Richter KD,
Wessel J, Schuck A, Willich N and Rube C: Dose-dependent induction
of transforming growth factor beta (TGF-beta) in the lung tissue of
fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol
Biol Phys. 47:1033–1042. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsukamoto H, Shibata K, Kajiyama H,
Terauchi M, Nawa A and Kikkawa F: Irradiation-induced
epithelial-mesenchymal transition (EMT) related to invasive
potential in endometrial carcinoma cells. Gynecol Oncol.
107:500–504. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Q, Mao A, Guo R, Zhang L, Yan J, Sun
C, Tang J, Ye Y, Zhang Y and Zhang H: Suppression of
radiation-induced migration of non-small cell lung cancer through
inhibition of Nrf2-Notch Axis. Oncotarget. 8:36603–36613. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kroeze SG, van Melick HH, Nijkamp MW,
Kruse FK, Kruijssen LW, van Diest PJ, Bosch JL and Jans JJ:
Incomplete thermal ablation stimulates proliferation of residual
renal carcinoma cells in a translational murine model. BJU Int.
110:E281–E286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shiozawa K, Watanabe M, Takahashi M, Wakui
N, Iida K and Sumino Y: Analysis of patients with rapid aggressive
tumor progression of hepatocellular carcinoma after percutaneous
radiofrequency ablation. Hepatogastroenterology. 56:1689–1695.
2009.PubMed/NCBI
|
|
16
|
Daly ME, Monjazeb AM and Kelly K: Clinical
trials integrating immunotherapy and radiation for non-small-cell
lung cancer. J Thorac Oncol. 10:1685–1693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao Z, Liang N, Yang H and Li S: Visfatin
mediates doxorubicin resistance in human non-small-cell lung cancer
via Akt-mediated up-regulation of ABCC1. Cell Prolif.
50:e123662017. View Article : Google Scholar
|
|
18
|
Wang G, Tian W, Liu Y, Ju Y, Shen Y, Zhao
S, Zhang B and Li Y: Visfatin triggers the cell motility of
non-small cell lung cancer via up-regulation of matrix
metalloproteinases. Basic Clin Pharmacol Toxicol. 119:548–554.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Okumura S, Sasaki T, Minami Y and Ohsaki
Y: Nicotinamide phosphoribosyltransferase: A potent therapeutic
target in non-small cell lung cancer with epidermal growth factor
receptor-gene mutation. J Thorac Oncol. 7:49–56. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Laiguillon MC, Houard X, Bougault C,
Gosset M, Nourissat G, Sautet A, Jacques C, Berenbaum F and Sellam
J: Expression and function of visfatin (Nampt), an adipokine-enzyme
involved in inflammatory pathways of osteoarthritis. Arthritis Res
Ther. 16:R382014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gujar AD, Le S, Mao DD, Dadey DY, Turski
A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, et al: An
NAD+-dependent transcriptional program governs
self-renewal and radiation resistance in glioblastoma. Proc Natl
Acad Sci USA. 113:E8247–E8256. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiang B, Han L, Wang X, Tang L, Li K, Li
X, Zhao X, Xia M, Zhou X, Zhang F, et al: Nicotinamide
phosphoribosyltransferase upregulation by phenylephrine reduces
radiation injury in submandibular gland. Int J Radiat Oncol Biol
Phys. 96:538–546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu W and Kang Y: Epithelial-mesenchymal
plasticity in cancer progression and metastasis. Dev Cell.
49:361–374. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Batlle E, Sancho E, Francí C, Domínguez D,
Monfar M, Baulida J and García De Herreros A: The transcription
factor snail is a repressor of E-cadherin gene expression in
epithelial tumour cells. Nat Cell Biol. 2:84–89. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang G, Ma W, Li Y, Jiang Y, Ma G, Zhang
X, Meng L and Du J: Prognostic value of Twist, Snail and E-cadherin
expression in pathological N0 non-small-cell lung cancer: A
retrospective cohort study. Eur J Cardiothorac Surg. 54:237–245.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yanagawa J, Walser TC, Zhu LX, Hong L,
Fishbein MC, Mah V, Chia D, Goodglick L, Elashoff DA, Luo J, et al:
Snail promotes CXCR2 ligand-dependent tumor progression in
non-small cell lung carcinoma. Clin Cancer Res. 15:6820–6829. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Zhang X, Ye M, Jing P, Xiong J,
Han Z, Kong J, Li M, Lai X, Chang N, et al: FBW7 loss promotes
epithelial-to-mesenchymal transition in non-small cell lung cancer
through the stabilization of Snail protein. Cancer Lett. 419:75–83.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin Y, Bai X, Zhou W, He Y, Wu Y and Wang
X: Radiation exposure triggers the progression of triple negative
breast cancer via stabilizing ZEB1. Biomed Pharmacother.
107:1624–1630. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Q, Yang G, Jiang Y, Luo M, Li C, Zhao
Y, Xie Y, Song K and Zhou J: XB130, regulated by miR-203, miR-219,
and miR-4782-3p, mediates the proliferation and metastasis of
non-small-cell lung cancer cells. Mol Carcinog. 59:557–568. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pecoraro A, Carotenuto P, Russo G and
Russo A: Ribosomal protein uL3 targets E2F1 and Cyclin D1 in cancer
cell response to nucleolar stress. Sci Rep. 9:154312019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lu L, Chen Z, Lin X, Tian L, Su Q, An P,
Li W, Wu Y, Du J, Shan H, et al: Inhibition of BRD4 suppresses the
malignancy of breast cancer cells via regulation of Snail. Cell
Death Differ. 27:255–268. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong P, Xiong Y, Watari H, Hanley SJ,
Konno Y, Ihira K, Yamada T, Kudo M, Yue J and Sakuragi N: MiR-137
and miR-34a directly target Snail and inhibit EMT, invasion and
sphere-forming ability of ovarian cancer cells. J Exp Clin Cancer
Res. 35:1322016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim R-K, Kaushik N, Suh Y, Yoo KC, Cui YH,
Kim MJ, Lee HJ, Kim IG and Lee SJ: Radiation driven
epithelial-mesenchymal transition is mediated by Notch signaling in
breast cancer. Oncotarget. 7:53430–53442. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feys L, Descamps B, Vanhove C, Vral A,
Veldeman L, Vermeulen S, De Wagter C, Bracke M and De Wever O:
Radiation-induced lung damage promotes breast cancer
lung-metastasis through CXCR4 signaling. Oncotarget. 6:26615–26632.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lagadec C, Vlashi E, Della Donna L,
Dekmezian C and Pajonk F: Radiation-induced reprogramming of breast
cancer cells. Stem Cells. 30:833–844. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rodriguez-Ruiz ME, Vitale I, Harrington
KJ, Melero I and Galluzzi L: Immunological impact of cell death
signaling driven by radiation on the tumor microenvironment. Nat
Immunol. 21:120–134. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Strieter RM, Belperio JA, Burdick MD,
Sharma S, Dubinett SM and Keane MP: CXC chemokines: Angiogenesis,
immunoangiostasis, and metastases in lung cancer. Ann NY Acad Sci.
1028:351–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Santaniello A, Napolitano F, Servetto A,
De Placido P, Silvestris N, Bianco C, Formisano L and Bianco R:
Tumour microenvironment and immune evasion in EGFR addicted NSCLC:
Hurdles and possibilities. Cancers (Basel). 11:14192019. View Article : Google Scholar
|
|
42
|
Liu T, Miao Z, Jiang J, Yuan S, Fang W, Li
B and Chen Y: Visfatin mediates SCLC cells migration across brain
endothelial cells through upregulation of CCL2. Int J Mol Sci.
16:11439–11451. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Uddin A and Chakraborty S: Role of miRNAs
in lung cancer. J Cell Physiol. Apr 20–2018.(Epub ahead of print).
doi: 10.1002/jcp.26607. View Article : Google Scholar
|
|
44
|
Wang Z and Liu C: MiR-153 regulates
metastases of gastric cancer through Snail. Tumour Biol.
37:15509–15515. 2015. View Article : Google Scholar
|
|
45
|
Zhang K, Li XY, Wang ZM, Han ZF and Zhao
YH: MiR-22 inhibits lung cancer cell EMT and invasion through
targeting Snail. Eur Rev Med Pharmacol Sci. 21:3598–3604.
2017.PubMed/NCBI
|
|
46
|
Cui YH, Suh Y, Lee HJ, Yoo KC, Uddin N,
Jeong YJ, Lee JS, Hwang SG, Nam SY, Kim MJ, et al: Radiation
promotes invasiveness of non-small-cell lung cancer cells through
granulocyte-colony-stimulating factor. Oncogene. 34:5372–5382.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qian L-W, Mizumoto K, Urashima T, Nagai E,
Maehara N, Sato N, Nakajima M and Tanaka M: Radiation-induced
increase in invasive potential of human pancreatic cancer cells and
its blockade by a matrix metalloproteinase inhibitor, CGS27023.
Clin Cancer Res. 8:1223–1227. 2002.PubMed/NCBI
|
|
48
|
Nambiar DK, Rajamani P and Singh RP:
Silibinin attenuates ionizing radiation-induced pro-angiogenic
response and EMT in prostate cancer cells. Biochem Biophys Res
Commun. 456:262–268. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhou YC, Liu JY, Li J, Zhang J, Xu YQ,
Zhang HW, Qiu LB, Ding GR, Su XM, Mei-Shi, et al: Ionizing
radiation promotes migration and invasion of cancer cells through
transforming growth factor-beta-mediated epithelial-mesenchymal
transition. Int J Radiat Oncol Biol Phys. 81:1530–1537. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang L, Zhao Y, Xiong Y, Wang W, Fei Y,
Tan C and Liang Z: K-ras mutation promotes ionizing
radiation-induced invasion and migration of lung cancer in part via
the Cathepsin L/CUX1 pathway. Exp Cell Res. 362:424–435. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Cho JH, Hong WG, Jung YJ, Lee J, Lee E,
Hwang SG, Um HD and Park JK: γ-Ionizing radiation-induced
activation of the EGFR-p38/ERK-STAT3/CREB-1-EMT pathway promotes
the migration/invasion of non-small cell lung cancer cells and is
inhibited by podophyllotoxin acetate. Tumour Biol. 37:7315–7325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Romacho T, Sánchez-Ferrer CF and Peiró C:
Visfatin/Nampt: An adipokine with cardiovascular impact. Mediators
Inflamm. 2013:9464272013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Carbone F, Liberale L, Bonaventura A,
Vecchiè A, Casula M, Cea M, Monacelli F, Caffa I, Bruzzone S,
Montecucco F, et al: Regulation and function of extracellular
nicotinamide phosphoribosyltransferase/visfatin. Compr Physiol.
7:603–621. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Liang N, Chen Y, Yang L, He S and Liu T:
Visfatin increases miR-21 to promote migration in HCC. Cell Mol
Biol. 64:48–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Yang J, Zhang K, Song H, Wu M, Li J, Yong
Z, Jiang S, Kuang X and Zhang T: Visfatin is involved in promotion
of colorectal carcinoma malignancy through an inducing EMT
mechanism. Oncotarget. 7:32306–32317. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yan X, Zhao J and Zhang R: Visfatin
mediates doxorubicin resis-tance in human colorectal cancer cells
via up regulation of multidrug resistance 1 (MDR1). Cancer
Chemother Pharmacol. 80:395–403. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Wang D, Qian G, Wang J, Wang T, Zhang L,
Yang P and Lin F: Visfatin is involved in the cisplatin resistance
of osteosarcoma cells via upregulation of Snail and Zeb1. Cancer
Biol Ther. 20:999–1006. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang Y, Yuan Y, Zhang Y, Cheng L, Zhou X
and Chen K: SNHG7 accelerates cell migration and invasion through
regulating miR-34a-Snail-EMT axis in gastric cancer. Cell Cycle.
19:142–152. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Tang Y, Tang Y and Cheng YS: miR-34a
inhibits pancreatic cancer progression through Snail1-mediated
epithelial-mesenchymal transition and the Notch signaling pathway.
Sci Rep. 7:382322017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hahn S, Jackstadt R, Siemens H, Hünten S
and Hermeking H: SNAIL and miR-34a feed-forward regulation of
ZNF281/ZBP99 promotes epithelial-mesenchymal transition. EMBO J.
32:3079–3095. 2013. View Article : Google Scholar : PubMed/NCBI
|
